11.50

2.54% -0.30

After Hours: 11.88 0.38 +3.30%

Instil Bio Inc (TIL)

Overview News Price History Option Chain Financials Discussions Forecast

Instil Bio Inc stock is currently priced at $11.50, with a 24-hour trading volume of 963. It has seen a -2.54% decreased in the last 24 hours and a +8.64% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $11.80 pivot point. If it approaches the $11.41 support level, significant changes may occur.

Previous Close:

$11.80

Open:

$11.79

24h Volume:

963

Market Cap:

$74.79M

Revenue:

Net Income/Loss:

$-156.09M

P/E Ratio:

-8.0986

EPS:

-1.42

Net Cash Flow:

$-102.69M

1W Performance:

-0.69%

1M Performance:

+8.64%

6M Performance:

+3,094%

1Y Performance:

+1,813%

1D Range:

$11.50

$11.88

52W Range:

$0.3035

$12.98

Instil Bio Inc Stock (TIL) Company Profile

Name

Instil Bio Inc

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

240-676-3715

Address

3963 Maple Avenue, Suite 350, Dallas

Employee

150

Twitter

Next Earnings Date

2024-06-13

Latest SEC Filings

TIL's Discussions on Twitter

Instil Bio Inc Stock (TIL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-01-22	Downgrade	Cowen	Outperform → Market Perform
Nov-01-22	Downgrade	Truist	Buy → Hold
Aug-13-21	Initiated	Robert W. Baird	Outperform
Apr-13-21	Initiated	Cowen	Outperform
Apr-13-21	Initiated	Morgan Stanley	Equal-Weight
Apr-13-21	Initiated	Truist	Buy

View All

Instil Bio Inc Stock (TIL) Latest News

(TIL) Long Term Investment Analysis - Stock Traders Daily

Stock Traders Daily

Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

GlobeNewswire

Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update - WICZ

WICZ

Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance

Yahoo Finance

(TIL) Proactive Strategies - Stock Traders Daily

Stock Traders Daily

Instil Bio Announces Board Reshuffle Following Resignation - TipRanks.com - TipRanks

TipRanks

Instil Bio Inc Stock (TIL) Financials Data

Instil Bio Inc (TIL) Net Income 2024

TIL net income (TTM) was -$156.09 million for the quarter ending December 31, 2023, a +30.06% increase year-over-year.

Instil Bio Inc (TIL) Cash Flow 2024

TIL recorded a free cash flow (TTM) of -$102.69 million for the quarter ending December 31, 2023, a +61.21% increase year-over-year.

Instil Bio Inc (TIL) Earnings per Share 2024

TIL earnings per share (TTM) was -$24.00 for the quarter ending December 31, 2023, a +30.23% growth year-over-year.

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 (FOLR1) with indications, including gynecological, non-small cell lung cancer, and others. The company was incorporated in 2018 and is based in Dallas, Texas.